Upon first exposure to a pathogen, our immune systems churn out specially trained B cells, which have learned to identify and ...

Recall germinal centers formed in response to a secondary infection generate a second line of defense, rebuffing memory B ...

B-cell activating factor receptor (BAFF-R) chimeric antigen receptor (CAR) T-cell therapy incited cytotoxic effects on both ...

Zenas BioPharma, Inc. (ZBIO) has received a new Buy rating, initiated by Citi analyst, Yigal Nochomovitz. Yigal Nochomovitz has given his Buy ...

For patients with relapsed/refractory large B-cell lymphoma (LBCL), the autologous, CD19-directed, 4-1BB chimeric antigen ...

The treatment, involving the use of donor cells, has shown positive results in patients six months after receiving treatment.

India continues to see a steady rise in the incidence of lymphoma, the most common type of blood cancer. But among all the ...

CAR-T cell products’ quality control standards incorporate characterization, uniformity, and purity testing to ensure and ...

This useful study reports that the exogenous expression of the microRNA miR-195 can partially compensate in early B cell development for the loss of EBF1, one of the key transcription factors in B ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the completion of the acquisition of ...

Inmates at category B HMP Nottingham who dislike constant loud music, shouting, swearing and singing are being offered 'low ...

Vera Therapeutics has come a long way towards the development of Atacicept for the treatment of patients with IgAN. Read more ...